Japan Lifeline Co (JP:7575) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Japan Lifeline Co. has entered into a five-year exclusive distribution agreement with Terumo Corporation for the sales of its radiofrequency ablation system, arfa, used for liver cancer treatment. This strategic partnership, starting in April 2025, aims to bolster Japan Lifeline’s market presence and achieve significant sales growth in the gastrointestinal field by 2028. The deal is expected to have a minor impact on Japan Lifeline’s business performance.
For further insights into JP:7575 stock, check out TipRanks’ Stock Analysis page.